Han Su

Han Su

Han Su, female, was born in Beijing in October 1960. He graduated from the Department of biology, Shandong University, majoring in animal science. After graduation, he engaged in reproductive endocrine research in the Department of Endocrinology, Institute of zoology, Chinese Academy of Sciences. Engaged in the separation and purification of hCG, preparation of hCG monoclonal antibody, etc.

He is currently a professor in the school of pharmacy of Nankai University.

Biography of characters

He studied in the Department of biology, Shandong University from 1978 to 1982. After graduation, he engaged in reproductive endocrine research in the Department of Endocrinology, Institute of zoology, Chinese Academy of Sciences. in 1985, he went to the Department of developmental biology, School of medicine, University of Cincinnati To study for a doctor's degree. He obtained his doctor's degree in 1991 for completing the work of "isolation and identification of human liver growth factor like gene". 1991-1998, worked as a research scientist in Symphony pharmaceutical Inc., an American pharmaceutical company, engaged in the research and development of new drugs for the treatment of Alzheimer's disease. in 1998, he returned to China and worked in Golden Lion Biopharmaceutical Technology Development Co., Ltd. as the project development manager, engaged in the research and establishment of a technology platform for human genetic engineering drug delivery system with Gram-positive bacteria, attracting investment from North China Pharmaceutical Group. from 2000 to 2002, he worked as the development manager of Hebei Kangxin Pharmaceutical Co., Ltd., and participated in the localization research and new drug application of peptide drugs such as thymosin α 1, octreotide and hirudin. in September 2003, he established Beijing Zhongtian Kangtai Biotechnology Co., Ltd. as a director and technical director, engaged in the research and development of peptide new drugs and peptide vaccines. In 2009, he participated in the establishment of Beijing Yuansen Kangtai Pharmaceutical Research Co., Ltd. as a director and technical director. in 2010, he participated in the establishment of yuansentai Biotechnology (Tianjin) Co., Ltd. as a director and technical director.

Professional direction

Engaged in the separation and purification of hCG, preparation of hCG monoclonal antibody, etc.